Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Inhibitory effects of marine-derived DNA-binding anti-tumour tetrahydroisoquinolines on the Fanconi anaemia pathway
Authors
Keywords
-
Journal
BRITISH JOURNAL OF PHARMACOLOGY
Volume 170, Issue 4, Pages 871-882
Publisher
Wiley
Online
2013-08-14
DOI
10.1111/bph.12331
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Mutations in ERCC4, Encoding the DNA-Repair Endonuclease XPF, Cause Fanconi Anemia
- (2013) Massimo Bogliolo et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Lurbinectedin (PM01183), a New DNA Minor Groove Binder, Inhibits Growth of Orthotopic Primary Graft of Cisplatin-Resistant Epithelial Ovarian Cancer
- (2012) A. Vidal et al. CLINICAL CANCER RESEARCH
- Trabectedin plus pegylated liposomal doxorubicin (PLD) versus PLD in recurrent ovarian cancer: Overall survival analysis
- (2012) Bradley J. Monk et al. EUROPEAN JOURNAL OF CANCER
- Molecular pathogenesis and clinical management of Fanconi anemia
- (2012) Younghoon Kee et al. JOURNAL OF CLINICAL INVESTIGATION
- FANCD2 but not FANCA promotes cellular resistance to type II topoisomerase poisons
- (2011) Lisa A. Kachnic et al. CANCER LETTERS
- XPF-Dependent DNA Breaks and RNA Polymerase II Arrest Induced by Antitumor DNA Interstrand Crosslinking-Mimetic Alkaloids
- (2011) Sascha Feuerhahn et al. CHEMISTRY & BIOLOGY
- Fanconi anaemia: from a monogenic disease to sporadic cancer
- (2011) Antonio Valeri et al. Clinical & Translational Oncology
- Zalypsis has in vitro activity in acute myeloid blasts and leukemic progenitor cells through the induction of a DNA damage response
- (2011) E. Colado et al. HAEMATOLOGICA
- Trabectedin and Its C Subunit Modified Analogue PM01183 Attenuate Nucleotide Excision Repair and Show Activity toward Platinum-Resistant Cells
- (2011) D. G. Soares et al. MOLECULAR CANCER THERAPEUTICS
- Temperature-induced melting of double-stranded DNA in the absence and presence of covalently bonded antitumour drugs: insight from molecular dynamics simulations
- (2011) Juan A. Bueren-Calabuig et al. NUCLEIC ACIDS RESEARCH
- Rationale for the opposite stereochemistry of the major monoadducts and interstrand crosslinks formed by mitomycin C and its decarbamoylated analogue at CpG steps in DNA and the effect of cytosine modification on reactivity
- (2011) Juan A. Bueren-Calabuig et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- PM01183, a new DNA minor groove covalent binder with potent in vitro and in vivo anti-tumour activity
- (2010) JFM Leal et al. BRITISH JOURNAL OF PHARMACOLOGY
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
- Animal research: Reporting in vivo experiments: The ARRIVE guidelines
- (2010) Carol Kilkenny et al. BRITISH JOURNAL OF PHARMACOLOGY
- Expanded roles of the Fanconi anemia pathway in preserving genomic stability
- (2010) Y. Kee et al. GENES & DEVELOPMENT
- FAVL elevation in human tumors disrupts Fanconi anemia pathway signaling and promotes genomic instability and tumor growth
- (2010) Jun Zhang et al. JOURNAL OF CLINICAL INVESTIGATION
- Genetic inactivation of the Fanconi anemia gene FANCC identified in the hepatocellular carcinoma cell line HuH-7 confers sensitivity towards DNA-interstrand crosslinking agents
- (2010) Andreas Palagyi et al. Molecular Cancer
- A Review of Trabectedin (ET-743): A Unique Mechanism of Action
- (2010) Maurizio D'Incalci et al. MOLECULAR CANCER THERAPEUTICS
- Molecular pharmacology and antitumor activity of Zalypsis ® in several human cancer cell lines
- (2009) Juan F.M. Leal et al. BIOCHEMICAL PHARMACOLOGY
- Targeting the Fanconi Anemia/BRCA Pathway Circumvents Drug Resistance in Multiple Myeloma
- (2009) D. N. Yarde et al. CANCER RESEARCH
- Zalypsis (PM00104) is a potent inducer of -H2AX foci and reveals the importance of the C ring of trabectedin for transcription-coupled repair inhibition
- (2009) J. Guirouilh-Barbat et al. MOLECULAR CANCER THERAPEUTICS
- The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair
- (2009) P. Knipscheer et al. SCIENCE
- Zalypsis: a novel marine-derived compound with potent antimyeloma activity that reveals high sensitivity of malignant plasma cells to DNA double-strand breaks
- (2008) E. M. Ocio et al. BLOOD
- Relevance of the Fanconi anemia pathway in the response of human cells to trabectedin
- (2008) J. A. Casado et al. MOLECULAR CANCER THERAPEUTICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now